We are live on ! Find out more
JCM

Jacobi Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+26.26%
3 Year Est. Return
+76.57%
5 Year Est. Return
+89.08%
10 Year Est. Return
+253.33%
AUM
$548M
AUM Growth
+$42.8M
Cap. Flow
+$5.29M
Cap. Flow %
0.96%
Top 10 Hldgs %
36.87%
Holding
1,138
New
47
Increased
346
Reduced
163
Closed
28

Sector Composition

Rank Sector Weight
1 Financials 11.09%
2 Healthcare 8.2%
3 Technology 7.41%
4 Industrials 6.02%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
226
Vanguard Dividend Appreciation ETF
VIG
$111B
$358K 0.07%
2,875
+81
+3% +$9.8K
LDSF icon
227
First Trust Low Duration Strategic Focus ETF
LDSF
$161M
$355K 0.06%
17,325
+11,280
+187% +$232K
ORCL icon
228
Oracle
ORCL
$374B
$354K 0.06%
6,675
+4,310
+182% +$237K
TD icon
229
Toronto Dominion Bank
TD
$198B
$351K 0.06%
6,252
+70
+1% +$3.97K
AZN icon
230
AstraZeneca
AZN
$263B
$338K 0.06%
3,394
EEMV icon
231
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$338K 0.06%
5,768
+458
+9% +$26.6K
XBI icon
232
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$336K 0.06%
3,528
BSV icon
233
Vanguard Short-Term Bond ETF
BSV
$44.7B
$332K 0.06%
4,115
+38
+0.9% +$3.07K
IVV icon
234
iShares Core S&P 500 ETF
IVV
$878B
$331K 0.06%
1,025
+5
+0.5% +$1.55K
EXC icon
235
Exelon
EXC
$47.2B
$325K 0.06%
9,981
-355
-3% -$11.5K
FBT icon
236
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$323K 0.06%
2,175
-52
-2% -$7.14K
FNCB
237
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$323K 0.06%
38,178
-3,998
-9% -$31.4K
UNH icon
238
UnitedHealth
UNH
$376B
$319K 0.06%
1,086
+8
+0.7% +$2.09K
IEF icon
239
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$316K 0.06%
2,809
-50
-2% -$5.58K
RDS.B
240
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$316K 0.06%
5,264
+160
+3% +$9.42K
FPE icon
241
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$311K 0.06%
15,498
+195
+1% +$3.88K
HBI
242
DELISTED
Hanesbrands
HBI
$303K 0.06%
20,412
-7,700
-27% -$117K
F icon
243
Ford
F
$58.5B
$296K 0.05%
31,830
-319
-1% -$2.87K
BX icon
244
Blackstone
BX
$102B
$289K 0.05%
5,170
+120
+2% +$6.23K
KMX icon
245
CarMax
KMX
$8.13B
$289K 0.05%
3,300
EEM icon
246
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$286K 0.05%
6,379
+616
+11% +$26.4K
CCL icon
247
Carnival Corporation Ltd
CCL
$38.1B
$285K 0.05%
5,604
-80
-1% -$3.57K
OHI icon
248
Omega Healthcare
OHI
$15.1B
$282K 0.05%
6,654
+94
+1% +$3.98K
EPD icon
249
Enterprise Products Partners
EPD
$82.3B
$279K 0.05%
9,891
+78
+0.8% +$2.11K
MTUM icon
250
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
$273K 0.05%
2,175
+600
+38% +$72.8K

Similar funds

Jacobi Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobi Capital Management held 1,138 positions worth $548M, up 8.5% from $505M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jacobi Capital Management's Q4 2019 filing shows 47 new, 346 increased, 163 reduced and 28 closed positions. Its largest new stake was Carlisle Companies: 1,500 shares worth $243K. The largest sale was Vanguard Total Bond Market, an estimated $12.9M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

  • Jacobi Capital Management's largest Q4 2019 buy was Carlisle Companies: 1,500 shares worth $243K.
  • Jacobi Capital Management added most to Vanguard FTSE All-World ex-US ETF in Q4 2019, an estimated $14.1M increase.
  • Jacobi Capital Management's biggest Q4 2019 reduction was Vanguard Total Bond Market, cutting an estimated $12.9M.
  • Jacobi Capital Management fully exited Vanguard Long-Term Corporate Bond ETF in Q4 2019, selling an estimated $3.24M.
  • Jacobi Capital Management's ten largest holdings make up 37% of its $548M portfolio in Q4 2019.
  • Jacobi Capital Management opened 47 new positions and closed 28 in Q4 2019.
  • Jacobi Capital Management's portfolio value rose 8.5% quarter-over-quarter to $548M.

Based on Jacobi Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.